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Abstract
Background: A six-fold increase in pediatric MRSA infections, prompted us to examine the clinical profile of
children with MRSA infections seen at Mercy Children’s Hospital, Toledo, Ohio and to characterize the responsible
strains.
Methods: Records were reviewed of pediatric patients who cultured positive for MRSA from June 1 to December
31, 2007. Strain typing by pulsed field gel electrophoresis (PFT) and DiversiLab, SCCmec typing, and PCR-based
lukSF-PV gene (encodes Panton-Valentine leukocidin), arginine catabolic mobile element (ACME) and cap5 gene
detection was performed.
Results: Chart review of 63 patients with MRSA infections revealed that 58(92%) were community acquired MRSA
(CAMRSA). All CAMRSA were skin and soft tissue infections (SSTI). Twenty five (43%) patients were aged < 3 yrs, 19
(33%) aged 4-12 and 14(24%) aged 13-18. Nineteen (76%) of those aged < 3 yrs had higher incidence of perineal
infections compared to only 2(11%) of the 4-12 yrs and none of the 13-18 yrs of age. Infections in the extremities
were more common in the older youth compared to the youngest children. Overall, there was a significant
association between site of the infection and age group (Fisher’s Exact p-value < 0.001). All CAMRSA were USA300
PFT, clindamycin susceptible, SCCmec type IVa and lukSF-PV gene positive. Nearly all contained ACME and about
80% were cap5 positive. Of the 58 USA300 strains by PFT, 55(95%) were also identified as USA300 via the
automated repetitive sequence-based PCR method from DiversiLab.
Conclusions: CAMRSA SSTI of the perineum was significantly more common among toddlers and that of the
extremities in older children. The infecting strains were all USA300 PFT. Further studies are needed to identify the
unique virulence and colonization characteristics of USA300 strains in these infections.
Background
Staphylococcus aureus (S. aureus) is a common human
commensal organism and a clinically important invasive
pathogen. Methicillin resistant S. aureus (MRSA)
remains one of the most prevalent pathogens isolated
from hospital patients. However, MRSA infections are
increasingly arising outside of healthcare settings among
individuals in the community with no established risk
factors. Furthermore, the incidence of invasive commu-
nity acquired MRSA (CAMRSA) disease in previously-
healthy children has been increasing [1-3].
CAMRSA strains as defined by the Centers for Disease
Control and Prevention (CDC) clinical criteria [4] have
some general characteristics that differentiate them from
healthcare associated MRSA (HAMRSA) strains, includ-
ing the presence of the Staphylococcal chromosomal
cassette - SCCmec type IVa that confers methicillin
resistance, lukSF-PV genes that codes for Panton-Valen-
tine leukocidin (PVL), arginine catabolic mobile element
(ACME) element that contributes to skin colonization
[5], antibiotic resistance patterns [3], and pulsed field
types (PFT) [6]. Several reports now show the migration
of these CAMRSA strains into the hospital setting [7-9].
A six-fold increase in the number of MRSA infections
among children between 2002 and 2007 (p < 0.0001)
(Figure 1) prompted us to examine both the clinical
profile of the patients, and the molecular profile of the
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Ohio. We also compared two strain typing methods -
pulsed field typing (PFT) and the automated rapid typ-
ing method using repetitive sequence-based PCR, the
DiversiLab system [10].
Methods
MRSA isolate collection and patient medical record
review
This is a retrospective, descriptive, single-cohort study
c o n d u c t e da tM e r c yC h i l d r e n ’s Hospital, Toledo, Ohio
and was approved by the institutional review board.
Pediatric patients (< 18 yrs of age), who were culture
positive for MRSA between June 1 to December 31,
2007, were identified by the clinical microbiology
laboratory (Mercy Integrated Laboratories, Toledo,
Ohio). This facility also provided us with a sample of
the clinical isolate that had been frozen at -80°C in a
solution of 50% brain-heart infusion and 50% glycerol
for later analysis.
Medical charts of these patients were reviewed for
social and demographic information including age, gen-
der, race, socio-economic status based on insurance, pre-
existing history of skin and soft tissue infection (SSTI);
respiratory, cardiovascular, gastrointestinal, and nervous
system diseases, type of care (outpatient vs.e m e r g e n c y
room vs. inpatient care) and site of infection. Antimicro-
bial susceptibilities were determined based on Clinical
and laboratory Standard Institute (CLSI) guidelines at the
clinical laboratory using the Vitek system for oxacillin,
erythromycin, clindamycin, vancomycin, ciprofloxacin,
tetracycline, trimethoprim/sulfamethoxasole, rifampin
and linezolid. All erythromycin-resistant strains were
tested for inducible clindamycin resistance using the D-
test [11] before final susceptibilities were reported.
Strain Typing
Pulsed Field typing (PFT): Strain typing was done by
PFT as described by Chang et al [12], using SmaIa st h e
restriction enzyme, at the Children’s Memorial Hospital,
Chicago, Illinois. The relatedness of isolates was based
on visual comparison of band patterns by the use of cri-
teria described by Tenover et al [13].
DiversiLab typing: Strain typing was also performed
using the DiversiLab System at Mercy Integrated
Laboratories. This is an automated method using repeti-
tive sequence-based PCR that targets multiple noncod-
ing repetitive sequences in the genomic DNA. Band
patterns were subsequently analyzed using the web-
based DiversiLab software [10].
DNA Extraction and PCR
Clinical isolates were grown on 5% blood agar plates
overnight at 37°C. DNA was extracted from the isolates
using the Wizard
® Genomic DNA Purification Kit. PCR
amplification was then performed on all patient isolates
for the presence of mecA,S C C mec typing, arcA, ACME,
lukSF-PV and cap5 genes (Additional file 1) [14-17].
Statistical Analysis
Fisher’s Exact test was used to explore for associations
of site of infection, pre-existing SSTI and respiratory
disease with age group and PFGE type. A Fisher’s Exact
p-value of < 0.05 was considered statistically significant.
Data were analyzed using SAS (SAS Cary, NC, version
9).
Results
From June 1, 2007 to December 31, 2007, 63 pediatric
patients with MRSA infections were seen at the emer-
gency room, outpatient clinics and the inpatient ward at
Mercy Children’s Hospital. Of these, only 5 patients did
not meet the CDC clinical criteria for CAMRSA [4].
Thus, 58 (92%) of all pediatric MRSA infections were
community-acquired. All of these CAMRSA infections
were SSTIs. During this time period there were no
other culture positive invasive pediatric MRSA infec-
tions like bacteremia, sepsis, endocarditis, pneumonia,
or osteomyelitis.
The patient characteristics for CAMRSA infections are
shown in Table 1. The turnover of patients at Mercy
Children’s Hospital in 2007 was about 22,000 (inpatients
2400) pediatric patients. In 2007, 26% of all children
seen at Mercy Children’s hospital were African Ameri-
can compared to 62% of our CAMRSA patients and;
51% were Medicaid insurance patients and therefore
belonged to the lower socio economic group compared
to 74% of our CAMRSA patients. All of these CAMRSA
isolates were susceptible to trimethoprim/sulfamethoxa-
sole, clindamycin, rifampin, linezolid and vancomycin.
The distribution of SSTI sites is shown in Table 2 and
reflects an age associated shift. In children ages 0-3
years, 19 (76%) had perineal SSTI which was more com-
mon. In contrast, only 2 (11%) of the children ages 4-12
 
•    •
Figure 1 Comparison of Pediatric MRSA Incidence in two time
periods five years apart: June 1st to Dec 31st 2002 and 2007
(p < 0.0001).
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Infections in the extremities were more common in the
older youth compared to the youngest children: 3 (12%)
in ages 0-3, 13 (68%) in ages 4-12, and 13 (93%) in ages
13-18. Overall, there was a significant association
between site of the infection and age group (Fisher’s
Exact p-value < 0.001) (Table 2).
Nineteen (33%) children had no pre-existing condi-
tion. Age group was not associated with having either
respiratory disease or SSTI as a pre-existing condition
(Fisher’s Exact p-values > 0.05 - Table 2). Pulsed field
typing (Smal PFT) of the 58 CAMRSA isolates revealed
that they were all USA300 PFT with seven different sub-
types (Figure 2), and one sub-type dominated in 72% (n
= 42) (Table 3). PFGE sub-type I (compared to sub-
types 2-7) was not associated with site of infection or
with having respiratory disease or SSTI as a pre-existing
condition, all with Fisher’s Exact p-values > 0.05 (Table
4). The DiversiLab typing of the 58 CAMRSA strains
revealed that 55 (95%) were indeed USA300 PFT while
3 strains were identified as USA500.
All 58 CAMRSA strains were mecA and lukSF-PV
positive, with SCCmec type IVa; 56 (97%) contained
ACME and the cap5 gene was present in 46 (79%)
(Table 3). We observed that all the cap5 negative strains
belonged to a single USA300 PFT pattern (Table 3 and
Figure 2).
Discussion
Figure 1 clearly demonstrates a six fold increase in the
incidence of pediatric MRSA infections from 2002 to
2007 (p < 0.0001). A clear majority of our pediatric
MRSA infections were CAMRSA, which is consistent
with the trend reported for the United States [18] and
Europe [19,20].
A significant association of age with site of infection
has for the first time been demonstrated in our study.
Table 1 Patient Characteristics
n (%)
Age group (years)
0-3 25 (43%)
4-12 19 (33%)
13-18 14 (24%)
Gender
Female 36 (62%)
Male 22 (38%)
Race
Caucasian 16 (29%)
African American 34 (62%)
Other 5 (9%)
Type of Visit
ER 27 (47%)
Inpatient 11 (19%)
Outpatient 20 (34%)
Insurance
Private 6 (11%)
Medicaid 43 (74%)
Uninsured 9 (16%)
Preexisting Conditions (patients may have more than 1)
SSTI 24 (41%)
Respiratory Disease 22 (38%)
Gastrointestinal 9 (16%)
Cardiovascular 3 (5%)
Nervous system 1 (2%)
None 19 (33%)
Site of Infection
Face 4 (7%)
Lower extremity 18 (31%)
Perineal 21 (36%)
Trunk 4 (7%)
Upper extremity 11 (19%)
ER: Emergency room, SSTI: Skin and soft tissue infection
Table 2 Associations with Age Group
Age 0-3
N=2 5
Age 4-12
N=1 9
Age 13-18
N=1 4
Fisher’s Exact Two-tailed P-value
Site of Infection < 0.001
Face 2 (8%) 1 (5%) 1 (7%)
Lower extremity 2 (8%) 8 (42%) 8 (57%)
Perineal 19 (76%) 2 (11%) 0 (0%)
Trunk 1 (4%) 3 (16%) 0 (0%)
Upper extremity 1 (4%) 5 (26%) 5 (36%)
Respiratory disease pre-existing condition 7 (28%) 9 (47%) 6 (43%) 0.42
SSTI pre-existing condition 12 (48%) 9 (47%) 3 (21%) 0.25
PFT Sub-type 1 (compared to types 2-7 combined) 19 (79%) 14 (74%) 9 (64%) 0.59
PFT: Pulse field type, SSTI: Skin and soft tissue infection
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recorded in the daycare setting [21]. Koski et al indicate
that pediatric perineal infections with MRSA are
increasing [22]. We found that such infections were
more common to the 0-3 y-old cohort. This age prefer-
ence could be due to increased rates of perineal
CAMRSA colonization in this age group, but may also
reflect use of diapers and possible dermabrasion caused
by vigorous wiping of the area during diaper changes or
both. Transfer of vancomycin resistance gene vanA
from vancomycin resistant Enterococcus to MRSA has
been shown to occur in vitro and in vivo [23]. Perineal
CAMRSA infection in children could contribute to the
emergence of vancomycin resistant S.aureus strains
when co-colonized with vancomycin resistant Enterococ-
cus [24].
Of interest, all of the CAMRSA strains in our study
were susceptible to clindamycin, contrary to higher rates
Figure 2 USA300 PFT subtypes. This is a picture of the USA300 strains all run on a single gel and are labeled according to the PFT subtypes in
Table 2, 3 & 4.
Table 3 Molecular epidemiology of USA300 PFT strains (n = 58)
USA300 PFT subtypes n(%) Diversilab type* n(%) mecA SCCmec type ACME lukSF-PV cap5
1-42(72%) USA300-41(98%)
USA500-1(24%)
42 IVa-42 42 42 30(71%)
2 - 6(10%) USA300-4(67%)
USA500-2(33%)
6 IVa-6 6 6 6
3 - 4(7%) USA300-4 4 IVa-4 4 4 4
4 - 2(3%) USA300-2 2 IVa-2 1 2 2
5 - 2(3%) USA300-2 2 IVa-2 2 2 2
6 - 1(2%) USA300-1 1 IVa-1 0 1 1
7 - 1(2%) USA300-1 1 IVa-1 1 1 1
Total(n) 58(100%) 58(100%) 58(100%) 56(97%) 58(100%) 46(79%)
PFT: Pulsed field type; SCC: Staphylococcal Cassette Chromosome, lukSF-PV genes that encode Panton-Valentine leukocidin (PVL), ACME: Arginine catabolic
mobile element.
*The DiversiLab strain types are named as corresponding PFT’s based on a standardized comparison.
For USA300 PFT subtypes please see figure 2.
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Francisco [25-27].
Strain typing of our patients’ MRSA isolates supports
the observation that USA300 PFT is the most common
causative strain and is clonal [27]. The molecular char-
acteristics of our isolates were similar to the USA300
strains from other published reports in that they were
SCCmec type IVa and lukSF-PV positive [27,28]. 56/58
of the strains were also positive for ACME, a novel
mobile genetic region predominantly reported in
USA300 MRSA strains that potentially enhance coloni-
zation and virulence [29]. We observed that all the 12
strains that were cap5 gene negative belonged to the
predominant USA300 PFT subtype (Table 3 and Figure
2). cap5 gene encodes for a capsule that enhances the
virulence of Staphylococcus aureus. It has been used as
vaccine target. The clinical significance of cap5 negative
strains in our study is unclear at this time.
Typing using the DiversiLab system is rapid and user
friendly compared to PFT. However, differentiating PFT
USA300 from USA500 is tricky using DiversiLab [30].
Of interest, 3/3 isolates identified by PFT as USA300
were mis-identified by DiversiLab as USA500. These iso-
lates were also positive for ACME which is a mobile
genetic element that is thought to be acquired by
USA300 as it evolved from its progenitor USA500 [31].
Conclusion
The incidence of CAMRSA infection is increasing in the
pediatric population of Northwest Ohio. SSTIs are the
most common type of infection and among children < 3
years of age with perineal SSTIs being the dominant
form caused by strain USA300 PFT that carries the
SCCmec type IVa, lukSF-PV gene and ACME. The auto-
mated rapid strain typing method, the DiversiLab sys-
tem, is not as discriminative as PFT.
Further investigations are needed to assess the extent
of USA300 perineal colonization in toddlers and to
identify unique virulence characteristics to develop stra-
tegies for prevention and treatment of these infections.
Additional material
Additional file 1: Primers used for the PCR reactions for mecA,
SCCmec typing, arcA, ACME, lukSF-PV and cap5 genes. Details of the
sequences of all the primers used in this study along with the references
are in the file.
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Lower extremity 11 (26%) 7 (43%)
Perineal 16 (38%) 5 (31%)
Trunk 4 (10%) 0 (0%)
Upper extremity 9 (21%) 2 (13%)
Respiratory disease pre-existing condition 15 (36%) 7 (47%) 0.54
SSTI pre-existing condition 18 (43%) 6 (40%) 1.0
PFT: Pulse field type, SSTI: Skin and soft tissue infection
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